Total Equity - EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 11.13 USD -0.27%

Updated:

EyePoint Pharmaceuticals Inc
Total Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

EyePoint Pharmaceuticals Inc
Total Equity Peer Comparison

JNJ

BMY

PFE

MRK

LLY

Company		Total Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
	EyePoint Pharmaceuticals Inc NASDAQ:EYPT	Total Equity $249.9m	CAGR 3-Years 29%	CAGR 5-Years 66%	CAGR 10-Years 30%
	Johnson & Johnson NYSE:JNJ	Total Equity $70B	CAGR 3-Years 2%	CAGR 5-Years 3%	CAGR 10-Years -1%
	Bristol-Myers Squibb Co NYSE:BMY	Total Equity $16.5B	CAGR 3-Years -24%	CAGR 5-Years 2%	CAGR 10-Years 1%
	Pfizer Inc NYSE:PFE	Total Equity $92.3B	CAGR 3-Years 10%	CAGR 5-Years 9%	CAGR 10-Years 2%
	Merck & Co Inc NYSE:MRK	Total Equity $40.4B	CAGR 3-Years 14%	CAGR 5-Years 8%	CAGR 10-Years -2%
	Eli Lilly and Co NYSE:LLY	Total Equity $12.8B	CAGR 3-Years 23%	CAGR 5-Years 39%	CAGR 10-Years -4%

See Also

Based on the financial report for Mar 31, 2024, EyePoint Pharmaceuticals Inc's Total Equity amounts to 249.9m USD.

Over the last year, the Total Equity growth was 219%. The average annual Total Equity growth rates for EyePoint Pharmaceuticals Inc have been 29% over the past three years , 66% over the past five years , and 30% over the past ten years .

Join more than 141,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.